International Congress Amsterdam 2015

Saturday, 26.09.2015 Sunday, 27.09.2015 Monday, 28.09.2015 Tuesday, 29.09.2015 Wednesday, 30.09.2015		Sponsored symposia: Evening Symposium organised by Novartis Pharma AG: "IgE-mediated asthma: New revelations and future insights" Evening Symposium organised by Boehringer Ingelheim International GmbH: "The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options" Industry early morning symposium organised by Novartis Pharma AG: "Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient"

Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.

ME4 Asthma susceptibility

Meet the expert
Chairs: –
Aims: To explain asthma susceptibility by presenting the results of basic science in relation to clinical observations. This will promote the development of personalised therapy on the basis of pathophysiology.
Target audience: Pulmonologists, paediatricians, respiratory therapists, basic scientists, trainees, and anyone with an interest in asthma

Educational Material

Handout ME4
Open

How to access educational materials from mobile devices

Download all media

Asthma susceptibility: from pathophysiology to personalised medicine Gerard Koppelman (Groningen, Netherlands)